Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-244142
Filing Date
2024-10-25
Accepted
2024-10-25 16:14:11
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d898035ds3.htm S-3 325203
2 EX-4.3 d898035dex43.htm EX-4.3 291448
3 EX-5.1 d898035dex51.htm EX-5.1 26805
4 EX-23.2 d898035dex232.htm EX-23.2 1550
5 EX-FILING FEES d898035dexfilingfees.htm EX-FILING FEES 38943
6 GRAPHIC g898035g03k03.jpg GRAPHIC 43404
7 GRAPHIC g898035g15z61.jpg GRAPHIC 8479
8 GRAPHIC g898035g68z30.jpg GRAPHIC 10567
  Complete submission text file 0001193125-24-244142.txt   771370
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282836 | Film No.: 241397229
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)